[Skip to Content]

Upstate Active Clinical Trials

Study Title:

LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with
Langerhans Cell Histiocytosis

What is the purpose of the study?

In this LCH-IV study, researchers want to find out if prolonging the treatment even further (from 12 months to 24 months) and adding another drug called 6-mercaptopurine will be beneficial. The goals of this study are to find out if these changes will result in fewer patients having a relapse of their LCH, and fewer patients having long-term disease-related problems.

Upstate Institutional Review Board (IRB) Number:

1020891

Study Phase:

Phase II/III

Patient Age Group:

Children

Principal Investigator:

Melanie A Comito

Who can I contact for more information?

Name: Karen B Bilynsky
Phone: 315-464-7601
Email: bilynskk@upstate.edu

Return to Previous Page || Search Again

Top